Nu Skin Enterprises (NUS) Projected to Announce Earnings on Thursday

Key Points

• Nu Skin Enterprises is expected to report Q3 2026 results on November 5 after the market closes, with analysts forecasting $0.21 in EPS and $328.7 million in revenue. The company’s Q3 EPS guidance is $0.10–$0.20, while full-year guidance is $0.70–$0.90.
• The company’s prior quarter met earnings expectations at $0.20 per share but fell short on revenue, posting $320.1 million versus the $345.2 million consensus estimate.
• NUS shares recently traded near $4.78, close to their 52-week low, while the company maintains a quarterly dividend of $0.06 per share, representing a 5% annualized yield. Analysts’ average rating is currently “Reduce.”

Nu Skin Enterprises (NYSE:NUS - Get Free Report) is projected to post its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to announce earnings of $0.21 per share and revenue of $328.70 million for the quarter. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. Parties may visit the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.20 earnings per share for the quarter, hitting analysts' consensus estimates of $0.20. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. The business had revenue of $320.11 million during the quarter, compared to the consensus estimate of $345.20 million. On average, analysts expect Nu Skin Enterprises to post $0.82 EPS for the current fiscal year and $1.16 EPS for the next fiscal year.

Nu Skin Enterprises Trading Up 1.0%

Shares of NYSE NUS opened at $4.78 on Thursday. The company's 50 day simple moving average is $4.77 and its 200 day simple moving average is $6.49. Nu Skin Enterprises has a fifty-two week low of $4.45 and a fifty-two week high of $11.67. The firm has a market capitalization of $232.43 million, a P/E ratio of -1.07 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.98 and a quick ratio of 1.24.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 9th. Shareholders of record on Friday, August 28th were given a dividend of $0.06 per share. The ex-dividend date was Friday, August 28th. This represents a $0.24 annualized dividend and a dividend yield of 5.0%. Nu Skin Enterprises's payout ratio is presently -5.37%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on NUS shares. Weiss Ratings downgraded Nu Skin Enterprises from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. Zacks Research upgraded Nu Skin Enterprises from a "strong sell" rating to a "hold" rating in a research report on Monday, October 12th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Reduce".

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.